FI108401B - Menetelmõ suun kautta annettavan, liuotinta sisõltõmõtt÷mõn, vaikuttavaa ainetta viivytetysti vapauttavan farmaseuttisen valmisteen valmistamiseksi - Google Patents

Menetelmõ suun kautta annettavan, liuotinta sisõltõmõtt÷mõn, vaikuttavaa ainetta viivytetysti vapauttavan farmaseuttisen valmisteen valmistamiseksi Download PDF

Info

Publication number
FI108401B
FI108401B FI931576A FI931576A FI108401B FI 108401 B FI108401 B FI 108401B FI 931576 A FI931576 A FI 931576A FI 931576 A FI931576 A FI 931576A FI 108401 B FI108401 B FI 108401B
Authority
FI
Finland
Prior art keywords
preparation
solvent
isosorbide
mixture
active substance
Prior art date
Application number
FI931576A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI931576A0 (fi
FI931576A (fi
Inventor
Rainer Schmidt
Bernhard Emschermann
Bernhard Sczepanik
Nch Ulrich M
Hans-J Rgen Mika
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6415859&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI108401(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Publication of FI931576A0 publication Critical patent/FI931576A0/fi
Publication of FI931576A publication Critical patent/FI931576A/fi
Application granted granted Critical
Publication of FI108401B publication Critical patent/FI108401B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI931576A 1990-10-08 1993-04-07 Menetelmõ suun kautta annettavan, liuotinta sisõltõmõtt÷mõn, vaikuttavaa ainetta viivytetysti vapauttavan farmaseuttisen valmisteen valmistamiseksi FI108401B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4031881A DE4031881C2 (de) 1990-10-08 1990-10-08 Lösungsmittelfreie, oral zu verabreichende pharmazeutische Zubereitung mit verzögerter Wirkstoffreisetzung und Verfahren zu deren Herstellung
DE4031881 1990-10-08
PCT/DE1991/000791 WO1992005774A1 (de) 1990-10-08 1991-10-07 Lösungsmittelfreie, oral zu verabreichende pharmazeutische zubereitung mit verzögerter wirkstofffreisetzung und verfahren zu deren herstellung
DE9100791 1991-10-07

Publications (3)

Publication Number Publication Date
FI931576A0 FI931576A0 (fi) 1993-04-07
FI931576A FI931576A (fi) 1993-04-07
FI108401B true FI108401B (fi) 2002-01-31

Family

ID=6415859

Family Applications (1)

Application Number Title Priority Date Filing Date
FI931576A FI108401B (fi) 1990-10-08 1993-04-07 Menetelmõ suun kautta annettavan, liuotinta sisõltõmõtt÷mõn, vaikuttavaa ainetta viivytetysti vapauttavan farmaseuttisen valmisteen valmistamiseksi

Country Status (24)

Country Link
US (1) US5453283A (ko)
EP (1) EP0552227B2 (ko)
JP (1) JP3233929B2 (ko)
KR (1) KR0166599B1 (ko)
AT (1) ATE116843T1 (ko)
CA (1) CA2093666C (ko)
CZ (1) CZ284923B6 (ko)
DE (2) DE4031881C2 (ko)
DK (1) DK0552227T4 (ko)
ES (1) ES2067250T5 (ko)
FI (1) FI108401B (ko)
GR (1) GR3015131T3 (ko)
HR (1) HRP920960B1 (ko)
HU (2) HUT64211A (ko)
IE (1) IE76142B1 (ko)
LV (1) LV11002B (ko)
PL (1) PL167593B1 (ko)
PT (1) PT99168B (ko)
RU (1) RU2101009C1 (ko)
SI (1) SI9111618B (ko)
SK (1) SK279446B6 (ko)
UA (1) UA26449C2 (ko)
WO (1) WO1992005774A1 (ko)
YU (1) YU48766B (ko)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE183641T1 (de) * 1992-12-23 1999-09-15 Saitec Srl Verfahren zur herstellung von arzneiformen und kontrollierte freigabe und die soerhaltenen arzneiformen
IL109460A (en) 1993-05-10 1998-03-10 Euro Celtique Sa Controlled release formulation comprising tramadol
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
DE4418837A1 (de) * 1994-05-30 1995-12-07 Bayer Ag Thermisches Granulierverfahren
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19504832A1 (de) * 1995-02-14 1996-08-22 Basf Ag Feste Wirkstoff-Zubereitungen
EP0818990A1 (en) * 1995-04-03 1998-01-21 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
HRP970485A2 (en) 1996-09-13 1998-08-31 Joerg Rosenberg Process for producing solid pharmaceutical forms
US5851555A (en) * 1997-08-15 1998-12-22 Fuisz Technologies Ltd. Controlled release dosage forms containing water soluble drugs
UA73092C2 (uk) * 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
DE10029201A1 (de) 2000-06-19 2001-12-20 Basf Ag Verfahren zur Herstellung fester oraler Darreichungsformen mit retardierender Wirkstoffreisetzung
CA2421885A1 (en) * 2000-10-27 2002-05-02 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
US20040029959A1 (en) * 2002-08-08 2004-02-12 John Devane Isosorbide mononitrate compositions and methods of their use
MY148074A (en) * 2005-05-10 2013-02-28 Novartis Ag Pharmaceutical compositions comprising imatinib and a release retardant
WO2007002597A2 (en) 2005-06-27 2007-01-04 Biovail Laboratories International S.R.L. Modified-release formulations of a bupropion salt
US20090246276A1 (en) 2008-01-28 2009-10-01 Graham Jackson Pharmaceutical Compositions
KR101659983B1 (ko) * 2012-12-31 2016-09-26 주식회사 삼양바이오팜 용융 압출된 방출 제어용 약학 조성물, 및 이를 포함하는 경구용 제제
WO2017086835A1 (ru) * 2015-11-17 2017-05-26 Общество С Ограниченной Ответственностью "Валента-Интеллект" Фармацевтическая композиция, обладающая терапевтическим эффектом в отношении демиелинизирующих заболеваний (варианты)
WO2019087084A1 (en) 2017-11-02 2019-05-09 Eman Biodiscoveries Sd. Bhd. Extract of orthosiphon stamineus, formulations, and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE636865A (ko) * 1962-08-31
US3308217A (en) * 1965-02-09 1967-03-07 Lowy Lawrence Method of granulating materials for subsequent forming into tablets
ES403326A1 (es) * 1971-06-04 1975-05-01 Boehringer Mannheim Gmbh Procedimiento para la granulacion de masas para tabletas enforma de polvo.
FR2581541B1 (fr) * 1985-05-09 1988-05-20 Rhone Poulenc Sante Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation
US5246714A (en) * 1985-10-11 1993-09-21 Aktiebolaget Hassle Drug preparation
DE3612211A1 (de) * 1986-04-11 1987-10-15 Basf Ag Kontinuierliches verfahren zum tablettieren
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale
DE3743945A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur abgabe von stoffen, verfahren zu ihrer herstellung sowie ihre verwendung
DE3743947A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur gesteuerten abgabe von nicotin, verfahren zu ihrer herstellung sowie ihre verwendung
DE3743946A1 (de) * 1987-09-01 1989-03-09 Lohmann Gmbh & Co Kg Vorrichtung zur abgabe von nitroglycerin an die haut, verfahren zu ihrer herstellung sowie ihre verwendung
DE3812567A1 (de) * 1988-04-15 1989-10-26 Basf Ag Verfahren zur herstellung pharmazeutischer mischungen
DE3812799A1 (de) * 1988-04-16 1989-10-26 Sanol Arznei Schwarz Gmbh Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung
DE3830353A1 (de) * 1988-09-07 1990-03-15 Basf Ag Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
US5262173A (en) * 1992-03-02 1993-11-16 American Cyanamid Company Pulsatile once-a-day delivery systems for minocycline

Also Published As

Publication number Publication date
SI9111618B (sl) 1999-08-31
ES2067250T3 (es) 1995-03-16
HU9300995D0 (en) 1993-07-28
KR0166599B1 (ko) 1999-01-15
UA26449C2 (uk) 1999-08-30
YU48766B (sh) 1999-12-27
EP0552227B1 (de) 1995-01-11
KR930701963A (ko) 1993-09-08
WO1992005774A1 (de) 1992-04-16
IE76142B1 (en) 1997-10-08
FI931576A0 (fi) 1993-04-07
PT99168A (pt) 1992-09-30
CA2093666A1 (en) 1992-04-09
GR3015131T3 (en) 1995-05-31
ATE116843T1 (de) 1995-01-15
YU161891A (sh) 1994-06-10
JP3233929B2 (ja) 2001-12-04
SI9111618A (en) 1997-12-31
DK0552227T3 (da) 1995-03-27
EP0552227B2 (de) 1998-11-04
HRP920960A2 (en) 1995-08-31
HU211845A9 (en) 1995-12-28
HRP920960B1 (en) 1998-10-31
SK279446B6 (sk) 1998-11-04
DK0552227T4 (da) 1999-07-19
EP0552227A1 (de) 1993-07-28
DE4031881C2 (de) 1994-02-24
PT99168B (pt) 1999-04-30
CZ284923B6 (cs) 1999-04-14
DE4031881A1 (de) 1992-04-09
HUT64211A (en) 1993-12-28
LV11002B (en) 1996-06-20
JPH06501685A (ja) 1994-02-24
LV11002A (lv) 1996-02-20
IE913592A1 (en) 1992-04-08
ES2067250T5 (es) 1999-02-01
CA2093666C (en) 1998-05-19
DE59104271D1 (de) 1995-02-23
PL167593B1 (pl) 1995-09-30
FI931576A (fi) 1993-04-07
RU2101009C1 (ru) 1998-01-10
CS305091A3 (en) 1992-04-15
US5453283A (en) 1995-09-26

Similar Documents

Publication Publication Date Title
FI108401B (fi) Menetelmõ suun kautta annettavan, liuotinta sisõltõmõtt÷mõn, vaikuttavaa ainetta viivytetysti vapauttavan farmaseuttisen valmisteen valmistamiseksi
KR100371885B1 (ko) 서방성매트릭스펠릿제및이들의제조방법
US3147187A (en) Sustained release pharmaceutical
US3279998A (en) Method of preparing sustained release tablets
CA1338553C (en) Pharmaceutical granulate containing cellulose product
JP2000505429A (ja) 揮発性塩を用いた可溶性デリバリーシステムの製造方法
KR20110016921A (ko) 분무 응결 단계의 사용하에 중간 분말 제형 및 최종 고체 용량형을 제조하는 방법
AU6043494A (en) Process for preparing controlled release pharmaceutical forms and the forms thus obtained
JPH10502056A (ja) 改質可能なでんぷんアセテート組成物およびその製造方法並びに使用方法
JP2000505801A (ja) トレハロースを含む固形製剤
AU753482B2 (en) Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates
KR100522239B1 (ko) 아세트아미노펜을 함유하는 제어방출성의 경구용 제제
HU217798B (hu) Eljárás szemcsés S(+)-ibuprofén előállítására és ezt tartalmazó készítmények
EP1467708A1 (en) New process 1
AU611740B2 (en) Pharmaceutical composition and process for its preparation
JPH0789875A (ja) 崩壊遅延防止錠剤
JPH0920686A (ja) 持続性製剤およびその製法
US5505963A (en) Slow release pharmaceutical preparation
JPH04243819A (ja) 徐放性製剤
RU2289422C2 (ru) Фармацевтическая композиция на основе ноопепта
JPH04164025A (ja) 徐放性錠剤の製造方法
JP2000072660A (ja) 凍結解凍造粒法
HU191102B (en) Process for producing pharmaceutical compositions of regulated dissolution of the active agents containing water-soluble inorganic pharmacons

Legal Events

Date Code Title Description
MA Patent expired